67 related articles for article (PubMed ID: 3258181)
1. Factors influencing anti-antibody enhancement of tumor targeting with antibodies in hamsters with human colonic tumor xenografts.
Sharkey RM; Mabus J; Goldenberg DM
Cancer Res; 1988 Apr; 48(8):2005-9. PubMed ID: 3258181
[TBL] [Abstract][Full Text] [Related]
2. Anti-antibody enhancement of iodine-131 anti-CEA radioimmunodetection in experimental and clinical studies.
Goldenberg DM; Sharkey RM; Ford E
J Nucl Med; 1987 Oct; 28(10):1604-10. PubMed ID: 3498807
[TBL] [Abstract][Full Text] [Related]
3. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
[TBL] [Abstract][Full Text] [Related]
4. Experimental radioimmunotherapy of a xenografted human colonic tumor (GW-39) producing carcinoembryonic antigen.
Goldenberg DM; Gaffar SA; Bennett SJ; Beach JL
Cancer Res; 1981 Nov; 41(11 Pt 1):4354-60. PubMed ID: 7306964
[TBL] [Abstract][Full Text] [Related]
5. Biological considerations for radioimmunotherapy.
Sharkey RM; Blumenthal RD; Hansen HJ; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):964s-969s. PubMed ID: 2297750
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen.
Sharkey RM; Pykett MJ; Siegel JA; Alger EA; Primus FJ; Goldenberg DM
Cancer Res; 1987 Nov; 47(21):5672-7. PubMed ID: 3664474
[TBL] [Abstract][Full Text] [Related]
7. Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice.
Sharkey RM; Boerman OC; Natale A; Pawlyk D; Monestier M; Losman MJ; Goldenberg DM
Int J Cancer; 1992 May; 51(2):266-73. PubMed ID: 1568794
[TBL] [Abstract][Full Text] [Related]
8. Use of second antibody in radioimmunotherapy.
Begent RH; Bagshawe KD; Pedley RB; Searle F; Ledermann JA; Green AJ; Keep PA; Chester KA; Glaser MG; Dale RG
NCI Monogr; 1987; (3):59-61. PubMed ID: 3493442
[TBL] [Abstract][Full Text] [Related]
9. Clearance of injected radioactively labelled antibodies to tumour products by liposome-bound second antibodies.
Keep PA; Searle F; Begent RH; Barratt GM; Boden J; Bagshawe KD; Ryman BE
Oncodev Biol Med; 1983; 4(4):273-80. PubMed ID: 6601263
[TBL] [Abstract][Full Text] [Related]
10. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
11. Quantitative whole-body autoradiography of radiolabeled antibody distribution in a xenografted human cancer model.
Fand I; Sharkey RM; McNally WP; Brill AB; Som P; Yamamoto K; Primus FJ; Goldenberg DM
Cancer Res; 1986 Jan; 46(1):271-7. PubMed ID: 3940196
[TBL] [Abstract][Full Text] [Related]
12. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of tumor-to-nontumor localization ratios by hepatocyte-directed blood clearance of antibodies labeled with certain residualizing radiolabels.
Patel S; Stein R; Ong GL; Goldenberg DM; Mattes MJ
J Nucl Med; 1999 Aug; 40(8):1392-401. PubMed ID: 10450693
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.
Sharkey RM; Kaltovich FA; Shih LB; Fand I; Govelitz G; Goldenberg DM
Cancer Res; 1988 Jun; 48(11):3270-5. PubMed ID: 3365705
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
[TBL] [Abstract][Full Text] [Related]
17. Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen.
Primus FJ; Wang RH; Goldenberg DM; Hansen HJ
Cancer Res; 1973 Nov; 33(11):2977-82. PubMed ID: 4800397
[No Abstract] [Full Text] [Related]
18. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points.
Kobayashi H; Le N; Kim IS; Kim MK; Pie JE; Drumm D; Paik DS; Waldmann TA; Paik CH; Carrasquillo JA
Cancer Res; 1999 Jan; 59(2):422-30. PubMed ID: 9927057
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.
Kraeber-Bodéré F; Faivre-Chauvet A; Saï-Maurel C; Campion L; Fiche M; Gautherot E; Le Boterff J; Barbet J; Chatal JF; Thédrez P
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3183s-3189s. PubMed ID: 10541362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
